Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) A combination of two resistance mechanisms is critical for tick-borne encephalitis virus escape from a broadly neutralizing human antibody
Cell Reports, 26 settembre 2023

2) ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells
British Journal of Haematology, 16 agosto 2023

3) Tau protein binds to the P53 E3 ubiquitin ligase MDM2
Scientific Reports, 23 giugno 2023

4) Myc controls NK cell development, IL-15-driven expansion, and translational machinery
Life Science Alliance, 27 aprile 2023

5) Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
The Lancet Regional Health Western Pacific, aprile 2023

6) Esmethadone-HCl (REL-1017): a promising rapid antidepressant
European Archives of Psychiatry and Clinical Neuroscience, 8 marzo 2023

7) Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course
Nature Immunology, 6 marzo 2023

8) Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
Science Immunology, 26 gennaio 2023

9) A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity
Science Translational Medicine, 21 dicembre 2022

10) Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2
bioRxiv, 28 novembre 2022

11) CEMIP (HYBID, KIAA1199): Structure, function and expression in health and disease
The FEBS Journal, 23 agosto 2022

12) Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors
Pharmaceuticals, 13 agosto 2022

13) Discovery of anti-Formin-like 1 protein (FMNL1) antibodies in membranous nephropathy and other glomerular diseases
Scientific Reports, 11 agosto 2022

14) Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19
Nature Immunology, 27 maggio 2022

15) Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course
bioRxiv, 23 maggio 2022

16) Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity
International Journal of Molecular Sciences, 3 maggio 2022

17) Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules
Nature Immunology, febbraio 2022

18) Management of transthyretin amyloidosis
Swiss Medical Weekly, 20 ottobre 2021

19) Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 Interaction
Journal of Medical Chemistry, 23 settembre 2021

20) Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease
Nature Communications, 2 agosto 2021

21) EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer
Nature Communications, 6 luglio 2021

22) Machine learning analyses of antibody somatic mutations predict immunoglobulin light chain toxicity
Nature Communications, 10 giugno 2021

23) Computational Identification of a Putative Allosteric Binding Pocket in TMPRSS2
Frontiers in Molecular Biosciences, 30 aprile 2021

24) Glomerular Macrophages in Human Auto- and Allo-Immune Nephritis
Cells, 9 marzo 2021

25) Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis
Swiss Medical Weekly, 5 dicembre 2020

26) How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs
Molecules, 10 aprile 2020

27) Endoplasmic Reticulum and Lysosomal Quality Control of Four Nonsense Mutants of Iduronate 2-Sulfatase Linked to Hunter's Syndrome.
DNA and Cell Biology, https://www.liebertpub.com/doi/10.1089/dna.2019.5221
Andrea Cavalli
is currently collaborating with
Istituto di Ricerca in Biomedicina (IRB) (Rif. IRB)
Via Francesco Chiesa 5
6500 Bellinzona
Andrea Cavalli
on behalf of Istituto di Ricerca in Biomedicina (IRB) USI (Rif. IRB)
is currently participating in the Research Group
Biologia Strutturale Computazionale
as Group Leader